Chapter | Block | Title |
---|---|---|
I | 001–139 | Infectious and Parasitic Diseases |
II | 140–239 | Neoplasms |
III | 240–279 | Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders |
IV | 280–289 | Diseases of the Blood and Blood-forming Organs |
V | 290–319 | Mental Disorders |
VI | 320–389 | Diseases of the Nervous System and Sense Organs |
VII | 390–459 | Diseases of the Circulatory System |
VIII | 460–519 | Diseases of the Respiratory System |
IX | 520–579 | Diseases of the Digestive System |
X | 580–629 | Diseases of the Genitourinary System |
XI | 630–679 | Complications of Pregnancy, Childbirth, and the Puerperium |
XII | 680–709 | Diseases of the Skin and Subcutaneous Tissue |
XIII | 710–739 | Diseases of the Musculoskeletal System and Connective Tissue |
XIV | 740–759 | Congenital Anomalies |
XV | 760–779 | Certain Conditions originating in the Perinatal Period |
XVI | 780–799 | Symptoms, Signs and Ill-defined Conditions |
XVII | 800–999 | Injury and Poisoning |
E800–E999 | Supplementary Classification of External Causes of Injury and Poisoning | |
V01–V82 | Supplementary Classification of Factors influencing Health Status and Contact with Health Services | |
M8000–M9970 | Morphology of Neoplasms |
This is a shortened version of the third chapter of the ICD-9: Endocrine, Nutritional and Metabolic Diseases, and Immunity Disorders. It covers ICD codes 240 to 279. The full chapter can be found on pages 145 to 165 of Volume 1, which contains all (sub)categories of the ICD-9. Volume 2 is an alphabetical index of Volume 1. Both volumes can be downloaded for free from the website of the World Health Organization.
| |||||
---|---|---|---|---|---|
Protein-energy malnutrition |
| ||||
Vitamin deficiency |
| ||||
Mineral deficiency |
| ||||
Growth |
| ||||
General |
|
Inborn errorofcarbohydrate metabolism: monosaccharide metabolism disorders
Including glycogen storage diseases (GSD) | |||||||||
---|---|---|---|---|---|---|---|---|---|
Sucrose, transport (extracellular) |
| ||||||||
Hexose → glucose |
| ||||||||
Glucose ⇄ glycogen |
| ||||||||
Glucose ⇄ CAC |
| ||||||||
Pentose phosphate pathway |
| ||||||||
Other |
|
| |||||
---|---|---|---|---|---|
Hyperlipidemia |
| ||||
Hypolipoproteinemia |
| ||||
Lipodystrophy |
| ||||
Other |
|
| |
---|---|
Anabolism |
|
Post-translational modification oflysosomal enzymes |
|
Catabolism |
|
Other |
|
| |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Sphingolipidoses (toceramide) |
| ||||||||||
NCL |
| ||||||||||
Other |
|
Immunoproliferative immunoglobulin disorders
| |
---|---|
PCDs/PP |
|
Other hypergammaglobulinemia |
|
Metal deficiency and toxicity disorders
| |||||
---|---|---|---|---|---|
Iron |
| ||||
Copper |
| ||||
Zinc |
| ||||
Other |
|
| |||||||
---|---|---|---|---|---|---|---|
Purine metabolism |
| ||||||
Pyrimidine metabolism |
|
Heme metabolism disorders
| |||||||
---|---|---|---|---|---|---|---|
Porphyria, hepatic and erythropoietic (porphyrin) |
| ||||||
Hereditary hyperbilirubinemia (bilirubin) |
|
| |||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|
Common amyloid forming proteins |
| ||||||||||
Systemic amyloidosis |
| ||||||||||
Organ-limited amyloidosis |
|
| |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Synthesis |
| ||||||||||||||||
Degradation |
|
Genetic disorder, organelle: Peroxisomal disorders and lysosomal structural disorders
| |
---|---|
Peroxisome biogenesis disorder |
|
Enzyme-related |
|
Transporter-related |
|
Lysosomal |
|
See also: proteins, intermediates |
| |
---|---|
Carbohydrate metabolism |
|
Primarily nervous system |
|
Myopathies |
|
No primary system |
|
Chromosomal |
|
see also mitochondrial proteins |
| |
---|---|
WHO-I/Langerhans cell histiocytosis/ X-type histiocytosis |
|
WHO-II/non-Langerhans cell histiocytosis/ Non-X histiocytosis |
|
WHO-III/malignant histiocytosis |
|
Ungrouped |
|
| |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Primary |
| ||||||||||||
Acquired |
| ||||||||||||
Leukopenia: Lymphocytopenia |
| ||||||||||||
Complement deficiency |
|